US20020123777A1 - Transcutaneous energy transfer with circuitry arranged to avoid overheating - Google Patents
Transcutaneous energy transfer with circuitry arranged to avoid overheating Download PDFInfo
- Publication number
- US20020123777A1 US20020123777A1 US10/004,731 US473101A US2002123777A1 US 20020123777 A1 US20020123777 A1 US 20020123777A1 US 473101 A US473101 A US 473101A US 2002123777 A1 US2002123777 A1 US 2002123777A1
- Authority
- US
- United States
- Prior art keywords
- coil
- circuitry
- magnetic flux
- subcircuits
- secondary coil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000013021 overheating Methods 0.000 title 1
- 230000004907 flux Effects 0.000 claims abstract description 74
- 230000003750 conditioning effect Effects 0.000 claims abstract description 65
- 238000000034 method Methods 0.000 claims abstract description 11
- 238000007920 subcutaneous administration Methods 0.000 claims description 16
- 239000008280 blood Substances 0.000 claims description 6
- 210000004369 blood Anatomy 0.000 claims description 6
- 239000000560 biocompatible material Substances 0.000 claims description 4
- 230000008878 coupling Effects 0.000 claims description 3
- 238000010168 coupling process Methods 0.000 claims description 3
- 238000005859 coupling reaction Methods 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 230000033228 biological regulation Effects 0.000 claims description 2
- 230000009931 harmful effect Effects 0.000 abstract 1
- 239000004020 conductor Substances 0.000 description 21
- 210000001519 tissue Anatomy 0.000 description 12
- 230000004888 barrier function Effects 0.000 description 10
- 230000006698 induction Effects 0.000 description 8
- 208000027418 Wounds and injury Diseases 0.000 description 7
- 238000010586 diagram Methods 0.000 description 6
- AGGKEGLBGGJEBZ-UHFFFAOYSA-N tetramethylenedisulfotetramine Chemical compound C1N(S2(=O)=O)CN3S(=O)(=O)N1CN2C3 AGGKEGLBGGJEBZ-UHFFFAOYSA-N 0.000 description 6
- 230000008901 benefit Effects 0.000 description 4
- 238000002513 implantation Methods 0.000 description 4
- 239000004065 semiconductor Substances 0.000 description 4
- 230000001143 conditioned effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 230000000149 penetrating effect Effects 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000003990 capacitor Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/372—Arrangements in connection with the implantation of stimulators
- A61N1/378—Electrical supply
- A61N1/3787—Electrical supply from an external energy source
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/20—Type thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/80—Constructional details other than related to driving
- A61M60/855—Constructional details other than related to driving of implantable pumps or pumping devices
- A61M60/871—Energy supply devices; Converters therefor
- A61M60/873—Energy supply devices; Converters therefor specially adapted for wireless or transcutaneous energy transfer [TET], e.g. inductive charging
- A61M60/875—Energy supply devices; Converters therefor specially adapted for wireless or transcutaneous energy transfer [TET], e.g. inductive charging specially adapted for optimising alignment of external and implantable coils
-
- H—ELECTRICITY
- H02—GENERATION; CONVERSION OR DISTRIBUTION OF ELECTRIC POWER
- H02J—CIRCUIT ARRANGEMENTS OR SYSTEMS FOR SUPPLYING OR DISTRIBUTING ELECTRIC POWER; SYSTEMS FOR STORING ELECTRIC ENERGY
- H02J50/00—Circuit arrangements or systems for wireless supply or distribution of electric power
- H02J50/10—Circuit arrangements or systems for wireless supply or distribution of electric power using inductive coupling
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3317—Electromagnetic, inductive or dielectric measuring means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/82—Internal energy supply devices
- A61M2205/8237—Charging means
- A61M2205/8243—Charging means by induction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/10—Location thereof with respect to the patient's body
- A61M60/122—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body
-
- H—ELECTRICITY
- H02—GENERATION; CONVERSION OR DISTRIBUTION OF ELECTRIC POWER
- H02J—CIRCUIT ARRANGEMENTS OR SYSTEMS FOR SUPPLYING OR DISTRIBUTING ELECTRIC POWER; SYSTEMS FOR STORING ELECTRIC ENERGY
- H02J2310/00—The network for supplying or distributing electric power characterised by its spatial reach or by the load
- H02J2310/10—The network having a local or delimited stationary reach
- H02J2310/20—The network being internal to a load
- H02J2310/23—The load being a medical device, a medical implant, or a life supporting device
Definitions
- the invention relates to the transfer of electromagnetic energy between a primary coil located outside the skin and a secondary coil located beneath the skin. More specifically, the invention concerns the circuitry used in connection with the secondary coil to condition the electromagnetic energy into a useful form.
- Many implanted medical devices are powered by electricity. Some devices, such as artificial pacemakers, may be battery-powered because their power requirements are comparatively low. Other devices require considerably more power and cannot be adequately supplied by a battery on a long-term basis.
- An implantable blood pump for example, requires considerably more power than an ordinary pacemaker. A pacemaker rhythmically generates electrical impulses to stimulate the heart muscle, but the pacemaker does not perform any mechanical pumping action. An implantable blood pump, by contrast, mechanically assists the heart muscle to pump blood, and for this reason has a considerably greater power requirement.
- Power requirements for a typical pacemaker may be on the order of 10 milliwatts, as compared with an implantable blood pump, which may have a power requirement one thousand times greater.
- Implantable electric storage batteries are unable to provide such power for long periods of time, and the frequent invasive surgery that would be required to replace the batteries makes this option undesirable. If the implantable batteries are rechargeable, then the batteries must be recharged from time to time, and power must in some way be delivered to recharge the batteries. Once again, use of invasive surgery to deliver the recharge is not a desirable alternative.
- the power source for a high-power device must be external to the body. To deliver the power to the device, the power must somehow transit through the skin. Power may be delivered through the skin by a percutaneous wire, but this method has drawbacks. A wire penetrating the skin provides a source for infection. Moreover, there is a risk that a wire penetrating the skin may accidentally be torn out, which may cause loss of power to the device and trauma to the patient.
- TET transcutaneous energy transfer
- Both the current in the primary coil and the current induced in the secondary coil are time-varying.
- Direct current (dc) will not result in a time-varying magnetic flux, and therefore will not create mutual induction.
- the current or voltage in the secondary coil must be conditioned for use by the device. Ordinarily, conditioning includes such functions as rectifying the current or voltage, filtering it to remove high-frequency components, and regulating it to provide substantially constant amounts of current or voltage.
- the present invention is directed to a transcutaneous energy transfer system having a secondary coil with integrated power conditioning circuitry.
- the transcutaneous energy transfer system may be particularly useful with an implantable blood pump having a pump control module.
- the pump control module ordinarily is implanted in the abdomen. Integration of the power conditioning circuitry with the secondary coil permits immediate conversion of energy induced at the secondary coil to dc current, instead of at the pump control module. Consequently, thinner leads can be used to couple the secondary coil to the pump control module, thus enhancing system versatility by expanding sites available for module implantation.
- the secondary coil and power conditioning circuitry can be arranged to provide a relatively low profile for implantation, while also limiting the generation of eddy currents in the power conditioning circuitry.
- Eddy currents in the power conditioning circuitry may be created when the circuitry is in proximity to the time-varying magnetic flux generated by the primary coil. A reduction in the generation of eddy currents helps avoid the creation of excessive heat in the area of the secondary coil, and resulting inflammation of nearby tissue.
- the power conditioning circuitry can be mounted within the aperture defined by the secondary coil with a structure and orientation designed to avoid coincidence with magnetic flux lines extending substantially perpendicular to the major plane defined by the secondary coil.
- power-conditioning circuitry is constructed as a substantially planar package or module.
- the circuitry may be placed on one or more circuit boards mounted within the aperture defined by the secondary coil and may be electrically connected to the secondary coil such that time-varying currents induced in the secondary coil are delivered to the conditioning circuitry.
- the conditioning circuitry may be encased in a nonconductive medium, the conditioning circuitry and circuit board may consist of conductors and semiconductors.
- the planar circuitry is oriented to reside within the coil aperture and occupy the major plane defined by the coil.
- Placement of the conditioning circuitry inside the secondary coil may have significant space-saving advantages, but may pose practical difficulties.
- the time-varying magnetic flux generated by the primary coil ordinarily will induce some time-varying eddy currents, in addition to the current induced within in the secondary coil.
- These induced eddy currents may appear in conductors and semiconductors in the power conditioning circuitry near the secondary coil. Eddy currents generate heat, due to the natural and inherent resistivity of the conductors.
- the present invention provides a way for the circuitry to be mounted within the secondary coil yet minimize eddy currents and thereby reduce the risk of excessive heating.
- TET systems may be in many forms, and the orientation of the lines of magnetic flux may be estimated. Where the primary and secondary coils are substantially circular and are axially aligned, for example, the location lines of magnetic flux can be reasonably estimated, especially along the diameters and near the centers of the coils.
- the circuitry attendant to the secondary coil may be substantially planar, and may be placed so that the plane of the circuitry is substantially tangent to the lines of magnetic flux.
- the lines of magnetic flux may pass through the major plane of the secondary coil at near-right angles, and magnetic flux lines near the center of the secondary coil's aperture may be substantially parallel to the secondary coil's axis.
- the present invention generally provides a device for use in transcutaneous energy transfer, comprising a coil for subcutaneous placement, and substantially planar circuitry electrically connected to the coil, wherein the plane of the circuitry is oriented substantially tangent to the lines of magnetic flux.
- the plane of the circuitry preferably is oriented substantially perpendicular to the major plane of the coil to minimize creation of eddy currents within the circuitry.
- the circuitry can be divided into sub-planes that are mounted adjacent one another in a stacked relationship.
- the circuitry may include two or more circuit planes with surface-mounted components that form a multi-plane circuit package, e.g., a “double-decker” or “triple-decker” arrangement.
- the circuit package may provide multiple interlocking circuit planes.
- the electrical components necessary for conditioning are distributed among two or more circuit planes, which may be individual printed circuit board sections.
- the circuitry may take on a curved shape. In this manner, the surface area and resulting height of each board section within the coil aperture can be reduced to thereby reduce the profile of the coil for implantation.
- the present invention provides a device for use in transcutaneous energy transfer, comprising a coil for subcutaneous placement within a human, and circuitry that is electrically connected to the coil, configured to conduct current induced in the coil.
- a major plane of the circuitry is oriented substantially perpendicular to a major plane of the coil, thereby reducing the generation of eddy currents within the circuitry while current is conducting in the coil.
- the circuitry may be located within the aperture of the coil.
- the circuitry may include substantially planar subcircuits, the planes of the subcircuits substantially located perpendicular to the major plane of the coil. Where the lines of magnetic flux are principally generated by a primary coil external to the skin, the substantially planar circuitry may be oriented substantially tangent to the lines of magnetic flux.
- the invention provides a TET system.
- the system comprises a primary coil for placement external to the skin, the coil suitable for carrying a time-varying current, and a current source arranged in series with the primary coil, comprising a power supply and power circuitry capable of delivering an electric current to the primary coil to produce magnetic flux.
- the system further comprises a secondary coil for subcutaneous placement, suitable for carrying a current induced by the magnetic flux.
- the system further comprises substantially planar conditioning circuitry that is electrically connected to the secondary coil and conducts current induced in the secondary coil, wherein the plane of the conditioning circuitry is oriented substantially perpendicular to the a major plane of the secondary coil.
- the system may further include a subcutaneous electrical device, connected to the conditioning circuitry by one or more leads.
- the invention provides a TETS method.
- the method comprises placing a primary coil external to the skin, the primary coil being electrically coupled to a power supply capable of delivering time-varying current to the primary coil.
- the method further comprises determining the orientation of magnetic flux lines principally caused by time-varying current circulating in the primary coil in proximity to a secondary coil that will be placed beneath the skin.
- the method further includes constructing conditioning circuitry in substantially planar fashion, and orienting the plane of the conditioning circuitry so it will be substantially tangent to the lines of magnetic flux.
- FIG. 1 is a simplified conceptual diagram of a coil and magnetic flux lines.
- FIG. 2 is a simplified conceptual diagram of a two-coil configuration illustrating transcutaneous energy transfer by mutual induction.
- FIG. 3A is a perspective diagram of a power conditioning circuit board.
- FIG. 3B is a cross-sectional view of two coils and an a power conditioning circuit board in accordance with an embodiment of the invention.
- FIG. 4 is a perspective view of a substantially planar circuitry arrangement in accordance with an embodiment of the invention.
- FIG. 5 is a perspective view of a substantially planar circuitry arrangement in accordance with an embodiment of the invention.
- FIG. 6 is a perspective view of a substantially planar yet curved circuitry arrangement in accordance with an embodiment of the invention.
- FIG. 1 is a conceptual diagram depicting magnetic flux lines 10 generated when a time-varying current i 1 ( 12 ) circulates in a closely-wound coil 14 .
- Coil 14 comprises at least one turn of electrically conductive wire.
- a closely-wound coil has multiple turns, and ordinarily has the turns closely-packed such that the magnetic flux through each turn is virtually the same.
- coil 14 is not depicted in FIG. 1 as closely-wound.
- FIG. 1 shows coil 14 with a substantially circular perimeter.
- the turns of coil 14 define a center opening or aperture 17 .
- Coil 14 also defines an axis 15 through the center of aperture 17 , perpendicularly intersecting major coil plane 13 .
- the turns of coil 14 lie substantially in major coil plane 13 .
- Other coils described below may have an aperture, axis and major coil plane, which may be defined in a similar manner.
- Time-varying current i 1 ( 12 ) is generated by a current source 16 .
- a magnetic field is created by a current-carrying conductor.
- Time-varying current i 1 ( 12 ) circulating in coil 14 causes coil 14 to behave like a magnetic dipole, with a corresponding magnetic field represented by magnetic flux lines 10 .
- magnetic flux lines 10 vary with time as well. As shown in FIG. 1, where the lines of magnetic flux 10 pass through the major coil plane 13 , the lines of magnetic flux 10 are essentially perpendicular to the major coil plane 13 .
- magnetic flux lines 10 near the center of aperture 17 are substantially parallel to the axis 15 of coil 14 .
- a thin, planar conductor 18 is depicted in FIG. 1 as near coil 14 , and some of the magnetic flux lines 10 pass through the surface of conductor 18 .
- the time-varying magnetic flux 10 may induce time-varying electromotive forces and time-varying currents within conductor 18 , according to Faraday's Law and Lenz's Law. Such time-varying currents may be referred to as “eddy currents.”
- current i 2 ( 20 ) is one of theoretically many eddy currents circulating within conductor 18 .
- the shape and direction of the path of eddy current i 2 ( 20 ) shown in FIG. 1 are arbitrary.
- the actual shape and direction of the eddy currents may be affected by the local shape and strength of the magnetic flux, and by whether the flux is locally increasing or decreasing.
- eddy currents may have a number of undesirable effects.
- eddy currents produce their own time-varying magnetic fields, which may interfere with the operation of other nearby electrical or electronic elements.
- ordinary (non-superconducting) conductors have inherent resistance to currents flowing in the conductors, and convert some of the electrical energy of eddy currents into thermal energy, or heat. Generation of excess heat may be especially detrimental in circumstances where circuitry may burn out, or in circumstances where the heat is sufficiently intense to cause a burn or other trauma to a patient's tissue.
- eddy currents generally represent an undesirable waste of energy.
- Eddy currents generally exist perpendicular to magnetic flux lines and depend upon the magnitude of magnetic flux flowing through the conductor.
- the magnetic flux is represented by flux lines 10 .
- Flux lines 10 passing through coil 14 are curved, but the flux lines intersect the coil's major plane 13 at substantially right angles.
- Flux lines 10 passing through conductor 18 can be broken down into two components: a tangent component parallel to the surface of conductor 18 , and a normal component perpendicular to the surface of conductor 18 .
- Eddy current i 2 ( 20 ) is perpendicular to the normal components of the flux lines. In general, the smaller the normal components of the flux lines passing through the conductor, the smaller the induced eddy currents within the conductor.
- FIG. 2 is a conceptual diagram depicting a two-coil configuration and block diagram illustrating transfer of power through a tissue barrier 30 by mutual induction.
- a time-varying current i 3 ( 26 ) is generated in a primary closely-wound coil 22 by a source 24 , creating time-varying magnetic flux 28 .
- Magnetic flux 28 may pass through tissue barrier 30 and may encounter a secondary, subcutaneous closely-wound coil 32 .
- Secondary coil 32 is implanted beneath tissue barrier 30 .
- Magnetic flux 28 inductively couples primary coil 22 and secondary coil 32 .
- a time-varying current i 4 ( 34 ) is induced in secondary coil 32 .
- the induced current i 4 ( 34 ) represents a time-varying or alternating current (ac) signal that may be conditioned by conditioning circuitry 36 .
- Conditioning circuitry 36 is ordinarily electrically coupled to secondary coil 32 . Conditioning may include, for example, rectification of the signal, filtering of the signal, and regulation of voltage or current levels. Currents and voltages conditioned by conditioning circuitry 36 may then be used by subcutaneous electrical device 38 , which is electrically coupled to conditioning circuitry 36 and is implanted beneath tissue barrier 30 .
- conditioning circuitry 36 may be electrically coupled to a control module that drives the device.
- conditioning circuitry 36 is depicted for ease of representation as a block outside the perimeter of secondary coil 32 .
- secondary coil 32 will be encapsulated in a casing of biocompatible material such as silicone prior to implantation, and placing conditioning circuitry 36 within the aperture of secondary coil 32 will allow the conditioning circuitry to be mounted within the aperture and to be encapsulated as well.
- Conditioning circuitry 36 may consist of electrical elements such as diodes, transistors, capacitors and resistors selected to convert the ac power from secondary coil 32 to dc power. Such circuitry can ordinarily be constructed in a substantially planar fashion, using conducting and semiconducting materials.
- the circuitry may take the form of a contiguous circuit package that includes the various electrical elements, and includes at least one terminal coupled to secondary coil 32 and at least one other terminal coupled to the control module of device 38 . The dc power then is transmitted from conditioning circuitry 36 to a control module that drives implantable device 38 .
- FIG. 2 illustrates one kind of transcutaneous energy transfer system.
- energy consumed by subcutaneous electrical device 38 is supplied from outside tissue barrier 30 by source 24 .
- the energy is transferred through tissue barrier 30 by way of inductive coupling between primary coil 22 and secondary coil 32 . It may also be said that the power, or energy per unit time, consumed by subcutaneous electrical device 38 is supplied from outside the skin by source 24 .
- FIG. 3A is a perspective drawing of power conditioning circuitry 50 .
- circuitry 50 has been constructed in a substantially planar fashion, and defines a major circuit plane 51 .
- Most of the conducting materials in conditioning circuitry 50 lie coincident with, tangent to or parallel to major circuit plane 51 .
- FIG. 3B is a cross-sectional view of a primary coil 40 and a secondary coil 42 .
- Secondary coil 42 is implanted beneath the tissue barrier 44 . The sizes and shapes of primary coil 40 and secondary coil 42 may vary.
- the axes 43 of primary coil 40 and secondary coil 42 coincide.
- a coil configuration in which the axes of the coils substantially coincide is called a “coaxial” configuration.
- the major coil plane 53 of primary coil 40 is approximately parallel to tissue barrier 44 , and is also approximately parallel to the major coil plane 49 of secondary coil 42 .
- axes 43 of both coils 40 , 42 are approximately perpendicular to tissue barrier 44 and to major coil planes 53 , 49 .
- major circuit plane 51 may be approximately aligned with a diameter of secondary coil 42 , substantially perpendicular to major coil plane 49 of secondary coil 42 .
- conditioning circuitry 50 may be located near the center of the aperture of secondary coil 42 .
- Conditioning circuitry 50 shown inside the aperture of secondary coil 42 in FIG. 3B is the same as conditioning circuitry 50 shown in FIG. 3A.
- Conditioning circuitry 50 is electrically coupled to secondary coil 42 by leads 48 .
- One or more leads may electrically couple circuitry 50 to a subcutaneous electrical device (not shown in FIG. 3B).
- Conditioning circuitry 50 holds a substantially fixed position relative to secondary coil 42 , and may be mounted within secondary coil 42 in many ways, such as by encapsulation within a casing of biocompatible material such as silicone.
- the magnetic flux lines 46 generated by passing current through primary coil 40 are generally parallel to coil axes 43 and are generally perpendicular to major coil plane 49 of secondary coil 42 , especially near the center of the aperture of secondary coil 42 .
- major circuit plane 51 of conditioning circuitry 50 has been oriented to be substantially parallel to coil axes 43 and perpendicular to the major coil plane 49 of secondary coil 42 .
- Such orientation places major circuit plane 51 of conditioning circuitry 50 substantially tangent to the magnetic flux lines 46 that conditioning circuitry 50 may encounter while current is passed through primary coil 40 .
- eddy currents within conditioning circuitry 50 are minimized. Consequently, undesirable heating and energy loss due to eddy currents within conditioning circuitry 50 are minimized.
- circuitry in place of or in addition to that related to conditioning the ac signal, may be oriented within the coil in a similar manner. It is also understood that conductive materials unrelated to circuitry may be so oriented so as to minimize eddy currents and attendant heat.
- FIG. 4 is a perspective view of conditioning circuitry 52 in which circuitry has been divided into two planar subcircuits 54 , 56 .
- Planar subcircuits 54 , 56 may be stacked in a “double-decker” fashion and may be connected by leads 58 .
- the plane of each subcircuit may be substantially tangent to the lines of magnetic flux.
- an additional subcircuit could be added, with the subcircuits stacked in “triple-decker” fashion. Any number of subcircuits may be coupled in this way, each subcircuit substantially tangent to the lines of magnetic flux.
- circuitry 60 is distributed among a plurality of planar subcircuits, each of which may be oriented within a secondary coil substantially tangent to the lines of magnetic flux.
- the subcircuits need not be stacked as shown in FIG. 4. Instead, the subcircuits may be arranged with interlocking circuit planes.
- FIG. 6 A further example of arrangement of circuitry appears in FIG. 6, in which the circuitry 62 is not strictly planar. As shown in FIGS. 1, 2 and 3 B, lines of magnetic flux are not necessarily straight. Therefore, circuitry may be applied to a curved surface that may still be substantially tangent to the lines of magnetic flux. Although the circuitry as a whole may be curved, locally the circuitry is substantially planar and substantially tangent to the lines of magnetic flux.
- FIGS. 4, 5 and 6 are merely exemplary. There are an infinite number of ways to arrange the circuitry to make it substantially tangent to the lines of magnetic flux. A circuit designer wishing to reduce the profile of the circuitry may employ any number of ways to distribute the electrical components necessary for conditioning among two or more circuit planes. Each circuit plane may then be positioned to make the plane substantially tangent to the lines of magnetic flux.
- the designer may distribute the electrical components along one or more curved surfaces, with each surface positioned to make the circuitry locally substantially tangent to the lines of magnetic flux.
- the present invention has the advantage of flexibility of circuit design, whereby the circuit designer has a wide range of options for arrangement of circuit elements to save space or to reduce the profile of the circuitry.
- the present invention has the further advantage of reducing the effects of eddy currents within the circuitry, thereby helping avoid generation of excess heat.
- the primary and secondary coils are depicted as simple coaxial coils.
- the depiction is for illustration only, and the present invention may have a far wider-ranging application.
- the coils need not be comparably sized, as depicted in FIG. 2.
- One coil may have a substantially larger radius than the other, and instead of placing the coils one atop the other, the coils may be placed one inside the other, assuming the tissue barrier is sufficiently deformable to permit such an arrangement. In this arrangement, the coils share substantially the same major plane and the same axis.
- the coils need not be in a coaxial configuration, which is only one of many configurations that may be used for transcutaneous energy transfer.
- other TETS configurations may include cores within the coils, or may have the coils wound in a solenoid-like fashion, or may have coils composed of various kinds of wire.
- tuning the coils for maximum efficient energy transfer, or for applying particular current oscillations.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Computer Networks & Wireless Communication (AREA)
- Mechanical Engineering (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Power Engineering (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Magnetic Treatment Devices (AREA)
Abstract
A device, system and method for transcutaneous energy transfer (TET). Implanted circuitry suitable for conditioning the power delivered transcutaneously may be constructed in planar fashion, may be located in or near an implanted coil, and may be oriented such that the plane of the circuitry is substantially tangent to the lines of magnetic flux. The orientation of the circuitry may reduce eddy currents and their potentially harmful effects.
Description
- The invention relates to the transfer of electromagnetic energy between a primary coil located outside the skin and a secondary coil located beneath the skin. More specifically, the invention concerns the circuitry used in connection with the secondary coil to condition the electromagnetic energy into a useful form.
- Many implanted medical devices are powered by electricity. Some devices, such as artificial pacemakers, may be battery-powered because their power requirements are comparatively low. Other devices require considerably more power and cannot be adequately supplied by a battery on a long-term basis. An implantable blood pump, for example, requires considerably more power than an ordinary pacemaker. A pacemaker rhythmically generates electrical impulses to stimulate the heart muscle, but the pacemaker does not perform any mechanical pumping action. An implantable blood pump, by contrast, mechanically assists the heart muscle to pump blood, and for this reason has a considerably greater power requirement.
- Power requirements for a typical pacemaker may be on the order of 10 milliwatts, as compared with an implantable blood pump, which may have a power requirement one thousand times greater. Implantable electric storage batteries are unable to provide such power for long periods of time, and the frequent invasive surgery that would be required to replace the batteries makes this option undesirable. If the implantable batteries are rechargeable, then the batteries must be recharged from time to time, and power must in some way be delivered to recharge the batteries. Once again, use of invasive surgery to deliver the recharge is not a desirable alternative.
- Ordinarily the power source for a high-power device must be external to the body. To deliver the power to the device, the power must somehow transit through the skin. Power may be delivered through the skin by a percutaneous wire, but this method has drawbacks. A wire penetrating the skin provides a source for infection. Moreover, there is a risk that a wire penetrating the skin may accidentally be torn out, which may cause loss of power to the device and trauma to the patient.
- Another way to deliver power through the skin is by way of induction. Two coils of electrically conductive wire, a primary coil external to the skin and a secondary coil implanted within the patient, may be inductively coupled. By energizing the primary coil with a time-varying current, a time-varying magnetic flux is produced by the primary coil. If the secondary coil is in proximity to the primary coil and is appropriately oriented, the time-varying magnetic flux will induce a time-varying current within the secondary coil, according to the principle of mutual induction. Power may be delivered through the skin using mutual induction. Systems delivering energy or power in this way are often called transcutaneous energy transfer, or TET, systems, sometimes referred to as TETS.
- Mutual induction is a consequence of Faraday's Law of Induction. Faraday's Law holds that the electromotive force (emf) in a conducting coil of N turns and the rate of change of magnetic flux through the coil are related. Faraday's Law is embodied within the equation E=−N(dΦ/dt), where E is the induced emf, N is the number of turns in the coil, and (d(Φ/dt) represents the change in magnetic flux with respect to time. The negative sign is a matter of convention, and is indicative of the direction of the induced emf.
- Both the current in the primary coil and the current induced in the secondary coil are time-varying. Direct current (dc) will not result in a time-varying magnetic flux, and therefore will not create mutual induction. If the device being powered operates using dc, the current or voltage in the secondary coil must be conditioned for use by the device. Ordinarily, conditioning includes such functions as rectifying the current or voltage, filtering it to remove high-frequency components, and regulating it to provide substantially constant amounts of current or voltage.
- The present invention is directed to a transcutaneous energy transfer system having a secondary coil with integrated power conditioning circuitry. The transcutaneous energy transfer system may be particularly useful with an implantable blood pump having a pump control module. The pump control module ordinarily is implanted in the abdomen. Integration of the power conditioning circuitry with the secondary coil permits immediate conversion of energy induced at the secondary coil to dc current, instead of at the pump control module. Consequently, thinner leads can be used to couple the secondary coil to the pump control module, thus enhancing system versatility by expanding sites available for module implantation.
- Importantly, the secondary coil and power conditioning circuitry can be arranged to provide a relatively low profile for implantation, while also limiting the generation of eddy currents in the power conditioning circuitry. Eddy currents in the power conditioning circuitry may be created when the circuitry is in proximity to the time-varying magnetic flux generated by the primary coil. A reduction in the generation of eddy currents helps avoid the creation of excessive heat in the area of the secondary coil, and resulting inflammation of nearby tissue. In particular, the power conditioning circuitry can be mounted within the aperture defined by the secondary coil with a structure and orientation designed to avoid coincidence with magnetic flux lines extending substantially perpendicular to the major plane defined by the secondary coil.
- Ordinarily, power-conditioning circuitry is constructed as a substantially planar package or module. The circuitry may be placed on one or more circuit boards mounted within the aperture defined by the secondary coil and may be electrically connected to the secondary coil such that time-varying currents induced in the secondary coil are delivered to the conditioning circuitry. Although the conditioning circuitry may be encased in a nonconductive medium, the conditioning circuitry and circuit board may consist of conductors and semiconductors. To reduce the profile of the secondary coil, the planar circuitry is oriented to reside within the coil aperture and occupy the major plane defined by the coil.
- Placement of the conditioning circuitry inside the secondary coil may have significant space-saving advantages, but may pose practical difficulties. The time-varying magnetic flux generated by the primary coil ordinarily will induce some time-varying eddy currents, in addition to the current induced within in the secondary coil. These induced eddy currents may appear in conductors and semiconductors in the power conditioning circuitry near the secondary coil. Eddy currents generate heat, due to the natural and inherent resistivity of the conductors.
- The present invention provides a way for the circuitry to be mounted within the secondary coil yet minimize eddy currents and thereby reduce the risk of excessive heating. TET systems may be in many forms, and the orientation of the lines of magnetic flux may be estimated. Where the primary and secondary coils are substantially circular and are axially aligned, for example, the location lines of magnetic flux can be reasonably estimated, especially along the diameters and near the centers of the coils.
- The present invention provides that the circuitry attendant to the secondary coil may be substantially planar, and may be placed so that the plane of the circuitry is substantially tangent to the lines of magnetic flux. In general, the lines of magnetic flux may pass through the major plane of the secondary coil at near-right angles, and magnetic flux lines near the center of the secondary coil's aperture may be substantially parallel to the secondary coil's axis.
- When the planar circuitry is oriented with its plane substantially tangent to the lines of magnetic flux, eddy currents within the conductors and semiconductors in the circuitry are reduced. In one aspect, the present invention generally provides a device for use in transcutaneous energy transfer, comprising a coil for subcutaneous placement, and substantially planar circuitry electrically connected to the coil, wherein the plane of the circuitry is oriented substantially tangent to the lines of magnetic flux. In preferred embodiments, the plane of the circuitry preferably is oriented substantially perpendicular to the major plane of the coil to minimize creation of eddy currents within the circuitry.
- To reduce the vertical profile of the circuitry relative to the major plane of the coil, the circuitry can be divided into sub-planes that are mounted adjacent one another in a stacked relationship. For example, the circuitry may include two or more circuit planes with surface-mounted components that form a multi-plane circuit package, e.g., a “double-decker” or “triple-decker” arrangement. Alternatively, the circuit package may provide multiple interlocking circuit planes.
- In either case, the electrical components necessary for conditioning are distributed among two or more circuit planes, which may be individual printed circuit board sections. As a further alternative, the circuitry may take on a curved shape. In this manner, the surface area and resulting height of each board section within the coil aperture can be reduced to thereby reduce the profile of the coil for implantation.
- In general, the present invention provides a device for use in transcutaneous energy transfer, comprising a coil for subcutaneous placement within a human, and circuitry that is electrically connected to the coil, configured to conduct current induced in the coil. A major plane of the circuitry is oriented substantially perpendicular to a major plane of the coil, thereby reducing the generation of eddy currents within the circuitry while current is conducting in the coil.
- The circuitry may be located within the aperture of the coil. The circuitry may include substantially planar subcircuits, the planes of the subcircuits substantially located perpendicular to the major plane of the coil. Where the lines of magnetic flux are principally generated by a primary coil external to the skin, the substantially planar circuitry may be oriented substantially tangent to the lines of magnetic flux.
- In another aspect, the invention provides a TET system. The system comprises a primary coil for placement external to the skin, the coil suitable for carrying a time-varying current, and a current source arranged in series with the primary coil, comprising a power supply and power circuitry capable of delivering an electric current to the primary coil to produce magnetic flux. The system further comprises a secondary coil for subcutaneous placement, suitable for carrying a current induced by the magnetic flux.
- The system further comprises substantially planar conditioning circuitry that is electrically connected to the secondary coil and conducts current induced in the secondary coil, wherein the plane of the conditioning circuitry is oriented substantially perpendicular to the a major plane of the secondary coil. The system may further include a subcutaneous electrical device, connected to the conditioning circuitry by one or more leads.
- In a further aspect, the invention provides a TETS method. The method comprises placing a primary coil external to the skin, the primary coil being electrically coupled to a power supply capable of delivering time-varying current to the primary coil. The method further comprises determining the orientation of magnetic flux lines principally caused by time-varying current circulating in the primary coil in proximity to a secondary coil that will be placed beneath the skin. The method further includes constructing conditioning circuitry in substantially planar fashion, and orienting the plane of the conditioning circuitry so it will be substantially tangent to the lines of magnetic flux.
- The details of one or more embodiments of the invention are set forth in the accompanying drawings and the description below. Other features, objects, and advantages of the invention will be apparent from the description and drawings, and from the claims.
- FIG. 1 is a simplified conceptual diagram of a coil and magnetic flux lines.
- FIG. 2 is a simplified conceptual diagram of a two-coil configuration illustrating transcutaneous energy transfer by mutual induction.
- FIG. 3A is a perspective diagram of a power conditioning circuit board.
- FIG. 3B is a cross-sectional view of two coils and an a power conditioning circuit board in accordance with an embodiment of the invention.
- FIG. 4 is a perspective view of a substantially planar circuitry arrangement in accordance with an embodiment of the invention.
- FIG. 5 is a perspective view of a substantially planar circuitry arrangement in accordance with an embodiment of the invention.
- FIG. 6 is a perspective view of a substantially planar yet curved circuitry arrangement in accordance with an embodiment of the invention.
- FIG. 1 is a conceptual diagram depicting
magnetic flux lines 10 generated when a time-varying current i1 (12) circulates in a closely-wound coil 14.Coil 14 comprises at least one turn of electrically conductive wire. A closely-wound coil has multiple turns, and ordinarily has the turns closely-packed such that the magnetic flux through each turn is virtually the same. For ease of representation,coil 14 is not depicted in FIG. 1 as closely-wound. FIG. 1 showscoil 14 with a substantially circular perimeter. The turns ofcoil 14 define a center opening oraperture 17.Coil 14 also defines anaxis 15 through the center ofaperture 17, perpendicularly intersectingmajor coil plane 13. The turns ofcoil 14 lie substantially inmajor coil plane 13. Other coils described below may have an aperture, axis and major coil plane, which may be defined in a similar manner. - Time-varying current i1 (12) is generated by a
current source 16. According to the Biot-Savart Law, a magnetic field is created by a current-carrying conductor. Time-varying current i1 (12) circulating incoil 14causes coil 14 to behave like a magnetic dipole, with a corresponding magnetic field represented by magnetic flux lines 10. As current i1 (12) varies with time,magnetic flux lines 10 vary with time as well. As shown in FIG. 1, where the lines ofmagnetic flux 10 pass through themajor coil plane 13, the lines ofmagnetic flux 10 are essentially perpendicular to themajor coil plane 13. In addition,magnetic flux lines 10 near the center ofaperture 17 are substantially parallel to theaxis 15 ofcoil 14. - A thin,
planar conductor 18 is depicted in FIG. 1 asnear coil 14, and some of themagnetic flux lines 10 pass through the surface ofconductor 18. The time-varyingmagnetic flux 10 may induce time-varying electromotive forces and time-varying currents withinconductor 18, according to Faraday's Law and Lenz's Law. Such time-varying currents may be referred to as “eddy currents.” In FIG. 1, current i2 (20) is one of theoretically many eddy currents circulating withinconductor 18. The shape and direction of the path of eddy current i2 (20) shown in FIG. 1 are arbitrary. The actual shape and direction of the eddy currents may be affected by the local shape and strength of the magnetic flux, and by whether the flux is locally increasing or decreasing. - In some circumstances, eddy currents may have a number of undesirable effects. For example, eddy currents produce their own time-varying magnetic fields, which may interfere with the operation of other nearby electrical or electronic elements. Also, ordinary (non-superconducting) conductors have inherent resistance to currents flowing in the conductors, and convert some of the electrical energy of eddy currents into thermal energy, or heat. Generation of excess heat may be especially detrimental in circumstances where circuitry may burn out, or in circumstances where the heat is sufficiently intense to cause a burn or other trauma to a patient's tissue. Furthermore, eddy currents generally represent an undesirable waste of energy.
- Eddy currents generally exist perpendicular to magnetic flux lines and depend upon the magnitude of magnetic flux flowing through the conductor. The magnetic flux is represented by
flux lines 10. Flux lines 10 passing throughcoil 14 are curved, but the flux lines intersect the coil'smajor plane 13 at substantially right angles. Flux lines 10 passing throughconductor 18 can be broken down into two components: a tangent component parallel to the surface ofconductor 18, and a normal component perpendicular to the surface ofconductor 18. Eddy current i2 (20) is perpendicular to the normal components of the flux lines. In general, the smaller the normal components of the flux lines passing through the conductor, the smaller the induced eddy currents within the conductor. The tangent components offlux lines 10 make no contribution to the creation of eddy currents. If the surface of theconductor 18 were tangent toflux lines 10, then only tangent components would be present, and there would be no normal component to the magnetic flux, and consequently no eddy currents would be induced. - FIG. 2 is a conceptual diagram depicting a two-coil configuration and block diagram illustrating transfer of power through a
tissue barrier 30 by mutual induction. A time-varying current i3 (26) is generated in a primary closely-wound coil 22 by asource 24, creating time-varyingmagnetic flux 28.Magnetic flux 28 may pass throughtissue barrier 30 and may encounter a secondary, subcutaneous closely-wound coil 32. For ease of representation,primary coil 22 and secondary coil 32 are not depicted in FIG. 2 as closely-wound. Secondary coil 32 is implanted beneathtissue barrier 30.Magnetic flux 28 inductively couplesprimary coil 22 and secondary coil 32. Asmagnetic flux 28 changes, a time-varying current i4 (34) is induced in secondary coil 32. - The induced current i4 (34) represents a time-varying or alternating current (ac) signal that may be conditioned by
conditioning circuitry 36.Conditioning circuitry 36 is ordinarily electrically coupled to secondary coil 32. Conditioning may include, for example, rectification of the signal, filtering of the signal, and regulation of voltage or current levels. Currents and voltages conditioned byconditioning circuitry 36 may then be used by subcutaneouselectrical device 38, which is electrically coupled toconditioning circuitry 36 and is implanted beneathtissue barrier 30. - Although not shown in FIG. 2,
conditioning circuitry 36 may be electrically coupled to a control module that drives the device. In FIG. 2,conditioning circuitry 36 is depicted for ease of representation as a block outside the perimeter of secondary coil 32. To save space and to makeconditioning circuitry 36 more easily implantable, it may be advantageous physically to place the conditioning circuitry inside the perimeter, within the aperture of secondary coil 32. Typically secondary coil 32 will be encapsulated in a casing of biocompatible material such as silicone prior to implantation, and placingconditioning circuitry 36 within the aperture of secondary coil 32 will allow the conditioning circuitry to be mounted within the aperture and to be encapsulated as well. -
Conditioning circuitry 36 may consist of electrical elements such as diodes, transistors, capacitors and resistors selected to convert the ac power from secondary coil 32 to dc power. Such circuitry can ordinarily be constructed in a substantially planar fashion, using conducting and semiconducting materials. The circuitry may take the form of a contiguous circuit package that includes the various electrical elements, and includes at least one terminal coupled to secondary coil 32 and at least one other terminal coupled to the control module ofdevice 38. The dc power then is transmitted fromconditioning circuitry 36 to a control module that drivesimplantable device 38. - FIG. 2 illustrates one kind of transcutaneous energy transfer system. In FIG. 2, energy consumed by subcutaneous
electrical device 38 is supplied fromoutside tissue barrier 30 bysource 24. The energy is transferred throughtissue barrier 30 by way of inductive coupling betweenprimary coil 22 and secondary coil 32. It may also be said that the power, or energy per unit time, consumed by subcutaneouselectrical device 38 is supplied from outside the skin bysource 24. - FIG. 3A is a perspective drawing of
power conditioning circuitry 50. As shown in FIG. 3A,circuitry 50 has been constructed in a substantially planar fashion, and defines amajor circuit plane 51. Most of the conducting materials inconditioning circuitry 50 lie coincident with, tangent to or parallel tomajor circuit plane 51. FIG. 3B is a cross-sectional view of aprimary coil 40 and asecondary coil 42.Secondary coil 42 is implanted beneath the tissue barrier 44. The sizes and shapes ofprimary coil 40 andsecondary coil 42 may vary. - As shown in FIG. 3B, the
axes 43 ofprimary coil 40 andsecondary coil 42 coincide. A coil configuration in which the axes of the coils substantially coincide is called a “coaxial” configuration. As shown in FIG. 3B, themajor coil plane 53 ofprimary coil 40 is approximately parallel to tissue barrier 44, and is also approximately parallel to themajor coil plane 49 ofsecondary coil 42. In addition, axes 43 of bothcoils major coil planes secondary coil 42 is substantially circular,major circuit plane 51 may be approximately aligned with a diameter ofsecondary coil 42, substantially perpendicular tomajor coil plane 49 ofsecondary coil 42. Furthermore,conditioning circuitry 50 may be located near the center of the aperture ofsecondary coil 42. -
Conditioning circuitry 50 shown inside the aperture ofsecondary coil 42 in FIG. 3B is the same asconditioning circuitry 50 shown in FIG. 3A.Conditioning circuitry 50 is electrically coupled tosecondary coil 42 by leads 48. One or more leads (not shown in FIG. 3B) may electrically couplecircuitry 50 to a subcutaneous electrical device (not shown in FIG. 3B).Conditioning circuitry 50 holds a substantially fixed position relative tosecondary coil 42, and may be mounted withinsecondary coil 42 in many ways, such as by encapsulation within a casing of biocompatible material such as silicone. Themagnetic flux lines 46 generated by passing current throughprimary coil 40 are generally parallel tocoil axes 43 and are generally perpendicular tomajor coil plane 49 ofsecondary coil 42, especially near the center of the aperture ofsecondary coil 42. - In the example of FIG. 3B,
major circuit plane 51 ofconditioning circuitry 50 has been oriented to be substantially parallel tocoil axes 43 and perpendicular to themajor coil plane 49 ofsecondary coil 42. Such orientation placesmajor circuit plane 51 ofconditioning circuitry 50 substantially tangent to themagnetic flux lines 46 thatconditioning circuitry 50 may encounter while current is passed throughprimary coil 40. By being oriented substantially tangent tomagnetic flux lines 46, eddy currents withinconditioning circuitry 50 are minimized. Consequently, undesirable heating and energy loss due to eddy currents withinconditioning circuitry 50 are minimized. - It is understood that circuitry, in place of or in addition to that related to conditioning the ac signal, may be oriented within the coil in a similar manner. It is also understood that conductive materials unrelated to circuitry may be so oriented so as to minimize eddy currents and attendant heat.
- In some circumstances, available space considerations or other considerations may make it difficult to place all of the conditioning circuitry in a single plane. There are many possible arrangements by which the circuitry may be oriented so as to minimize eddy currents. One such example appears in FIG. 4. FIG. 4 is a perspective view of
conditioning circuitry 52 in which circuitry has been divided into twoplanar subcircuits Planar subcircuits secondary coil 42 shown in FIG. 3B, the plane of each subcircuit may be substantially tangent to the lines of magnetic flux. In a similar manner, an additional subcircuit could be added, with the subcircuits stacked in “triple-decker” fashion. Any number of subcircuits may be coupled in this way, each subcircuit substantially tangent to the lines of magnetic flux. - Another example of arrangement of circuitry appears in FIG. 5, in which
circuitry 60 is distributed among a plurality of planar subcircuits, each of which may be oriented within a secondary coil substantially tangent to the lines of magnetic flux. As shown in FIG. 5, the subcircuits need not be stacked as shown in FIG. 4. Instead, the subcircuits may be arranged with interlocking circuit planes. - A further example of arrangement of circuitry appears in FIG. 6, in which the
circuitry 62 is not strictly planar. As shown in FIGS. 1, 2 and 3B, lines of magnetic flux are not necessarily straight. Therefore, circuitry may be applied to a curved surface that may still be substantially tangent to the lines of magnetic flux. Although the circuitry as a whole may be curved, locally the circuitry is substantially planar and substantially tangent to the lines of magnetic flux. - The arrangements shown in FIGS. 4, 5 and6 are merely exemplary. There are an infinite number of ways to arrange the circuitry to make it substantially tangent to the lines of magnetic flux. A circuit designer wishing to reduce the profile of the circuitry may employ any number of ways to distribute the electrical components necessary for conditioning among two or more circuit planes. Each circuit plane may then be positioned to make the plane substantially tangent to the lines of magnetic flux.
- Alternatively, the designer may distribute the electrical components along one or more curved surfaces, with each surface positioned to make the circuitry locally substantially tangent to the lines of magnetic flux. The present invention has the advantage of flexibility of circuit design, whereby the circuit designer has a wide range of options for arrangement of circuit elements to save space or to reduce the profile of the circuitry. The present invention has the further advantage of reducing the effects of eddy currents within the circuitry, thereby helping avoid generation of excess heat.
- In FIGS. 2 and 3B, the primary and secondary coils are depicted as simple coaxial coils. The depiction is for illustration only, and the present invention may have a far wider-ranging application. For example, the coils need not be comparably sized, as depicted in FIG. 2. One coil may have a substantially larger radius than the other, and instead of placing the coils one atop the other, the coils may be placed one inside the other, assuming the tissue barrier is sufficiently deformable to permit such an arrangement. In this arrangement, the coils share substantially the same major plane and the same axis.
- Furthermore, the coils need not be in a coaxial configuration, which is only one of many configurations that may be used for transcutaneous energy transfer. In addition to the positions and sizes of the coils, other TETS configurations may include cores within the coils, or may have the coils wound in a solenoid-like fashion, or may have coils composed of various kinds of wire. There may also be a multitude of ways for tuning the coils for maximum efficient energy transfer, or for applying particular current oscillations.
- Although there may be a wide assortment of configurations used for TETS, many configurations for TETS involve magnetic flux, and may have the potential to create undesirable eddy currents. The present invention, relating to orientation of the conditioning circuitry to make the circuitry substantially tangent to the lines of magnetic flux, may be applied to these other TETS configurations.
- The foregoing detailed description has been provided for a better understanding of the invention and is for exemplary purposes only. Modifications may be apparent to those skilled in the art, however, without deviating from the spirit and scope of the appended claims. Other embodiments are within the scope of the following claims.
Claims (28)
1. A device for use in transcutaneous energy transfer, comprising:
a coil for subcutaneous placement within a human, and circuitry that is electrically connected to the coil, and configured to conduct current induced in the coil,
wherein a major plane of the circuitry is oriented substantially perpendicular to a major plane of the coil, thereby reducing the generation of eddy currents within the circuitry while current is conducting in the coil.
2. The device of claim 1 , further comprising a casing composed of biocompatible material encapsulating the coil and the circuitry.
3. The device of claim 1 , wherein the circuitry is located within the aperture of the coil.
4. The device of claim 1 , further comprising leads permitting attachment to a subcutaneous electrical device.
5. The device of claim 1 , wherein the shape of the coil is substantially circular.
6. The device of claim 1 , wherein the circuitry is located near the axis of the coil.
7. The device of claim 1 , wherein the circuitry consists of substantially planar subcircuits, the planes of the subcircuits are substantially located perpendicular to the major plane of the coil.
8. The device of claim 1 , wherein the circuitry consists of planar subcircuits, the subcircuits being electrically coupled by leads, and the major planes of the subcircuits being substantially parallel to each other.
9. The device of claim 1 , wherein the coil is a secondary coil, and wherein the lines of magnetic flux are principally generated by a primary coil external to the skin.
10. The device of claim 9 , wherein the substantially planar circuitry is oriented substantially tangent to the lines of magnetic flux generated by the primary coil.
11. The device of claim 9 , wherein the substantially planar circuitry is curved such that the local plane of the circuitry is oriented substantially tangent to the lines of magnetic flux generated by the primary coil.
12. The device of claim 9 , wherein the primary coil and the secondary coil are arranged coaxially.
13. A transcutaneous energy transfer system, comprising
a primary coil for placement external to the skin, the coil suitable for carrying a time-varying current,
a current source arranged in series with the primary coil, comprising a power supply and power circuitry capable of delivering an electric current to the primary coil to produce magnetic flux,
a secondary coil for subcutaneous placement, the coil suitable for carrying a current induced by the magnetic flux, and
substantially planar conditioning circuitry that is electrically coupled to the secondary coil and conducts current induced in the secondary coil,
wherein the plane of the conditioning circuitry is oriented substantially perpendicular to the a major plane of the secondary coil.
14. The system of claim 13 , wherein the conditioning circuitry performs at least one of the functions of rectification, filtering and regulation.
15. The system of claim 13 , further comprising:
a subcutaneous electrical device, and
leads permitting electrical coupling of the conditioning circuitry to the subcutaneous electrical device.
16. The system of claim 15 , wherein the subcutaneous electrical device comprises an implantable blood pump.
17. The system of claim 15 , wherein the subcutaneous electrical device comprises an electrical storage battery.
18. The system of claim 13 , wherein the conditioning circuitry is located within the aperture of the secondary coil.
19. The system of claim 13 , wherein the primary and secondary coils are arranged coaxially.
20. The system of claim 13 , wherein the shape of the primary coil is substantially circular and the shape of the secondary coil is substantially circular.
21. The system of claim 13 , wherein the plane of the conditioning circuitry is located substantially perpendicular to the major plane of the primary coil.
22. The system of claim 13 , wherein the conditioning circuitry is oriented to reduce eddy currents induced by the magnetic flux.
23. The system of claim 13 , wherein the conditioning circuitry comprises two or more electrically coupled substantially planar subcircuits, the plane of the subcircuits being oriented substantially perpendicular to the a major plane of the secondary coil.
24. The system of claim 13 , wherein the conditioning circuitry comprises two or more electrically coupled subcircuits, the subcircuits being oriented to reduce eddy currents induced by the magnetic flux.
25. A method for delivering energy transcutaneously, the method comprising:
placing a primary coil external to the skin, the primary coil being electrically coupled to a power supply capable of delivering time-varying current to the primary coil,
determining the orientation of magnetic flux lines principally caused by time-varying current circulating in the primary coil,
constructing conditioning circuitry in substantially planar fashion, and
placing a secondary coil beneath the skin, the secondary coil being electrically connected to the conditioning circuitry and the conditioning circuitry oriented substantially tangent to the lines of magnetic flux.
26. The method of claim 25 , further comprising
dividing the conditioning circuitry into subcircuits, each subcircuit being substantially planar;
electrically coupling the subcircuits, and
orienting the planes of the subcircuits within the aperture of the secondary coil substantially parallel to the lines of magnetic flux.
27. The method of claim 26 , further comprising placing the planes of the subcircuits in a substantially parallel stacked configuration.
28. The method of 25, further comprising encapsulating the secondary coil and the conditioning circuitry within a casing composed of biocompatible material.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/004,731 US20020123777A1 (en) | 2000-05-10 | 2001-12-04 | Transcutaneous energy transfer with circuitry arranged to avoid overheating |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/567,942 US6327504B1 (en) | 2000-05-10 | 2000-05-10 | Transcutaneous energy transfer with circuitry arranged to avoid overheating |
US10/004,731 US20020123777A1 (en) | 2000-05-10 | 2001-12-04 | Transcutaneous energy transfer with circuitry arranged to avoid overheating |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/567,942 Continuation US6327504B1 (en) | 2000-05-10 | 2000-05-10 | Transcutaneous energy transfer with circuitry arranged to avoid overheating |
Publications (1)
Publication Number | Publication Date |
---|---|
US20020123777A1 true US20020123777A1 (en) | 2002-09-05 |
Family
ID=24269260
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/567,942 Expired - Lifetime US6327504B1 (en) | 2000-05-10 | 2000-05-10 | Transcutaneous energy transfer with circuitry arranged to avoid overheating |
US10/004,731 Abandoned US20020123777A1 (en) | 2000-05-10 | 2001-12-04 | Transcutaneous energy transfer with circuitry arranged to avoid overheating |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/567,942 Expired - Lifetime US6327504B1 (en) | 2000-05-10 | 2000-05-10 | Transcutaneous energy transfer with circuitry arranged to avoid overheating |
Country Status (5)
Country | Link |
---|---|
US (2) | US6327504B1 (en) |
EP (1) | EP1280581B1 (en) |
AU (1) | AU2001261396A1 (en) |
DE (1) | DE60143519D1 (en) |
WO (1) | WO2001085250A1 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7191013B1 (en) | 2004-11-08 | 2007-03-13 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Hand held device for wireless powering and interrogation of biomems sensors and actuators |
US20070118038A1 (en) * | 2005-11-23 | 2007-05-24 | Vital Sensors Inc. | Implantable device for telemetric measurement of blood pressure/temperature within the heart |
US7682313B2 (en) | 2005-11-23 | 2010-03-23 | Vital Sensors Holding Company, Inc. | Implantable pressure monitor |
US7771351B1 (en) * | 2005-05-27 | 2010-08-10 | The Cleveland Clinic Foundation | Method and apparatus for eddy current compensation in a radio frequency probe |
US7794499B2 (en) | 2004-06-08 | 2010-09-14 | Theken Disc, L.L.C. | Prosthetic intervertebral spinal disc with integral microprocessor |
US20110166619A1 (en) * | 2008-06-18 | 2011-07-07 | Nasophlex B.V | Ear stimulator for producing a stimulation signal to an ear |
Families Citing this family (139)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7713297B2 (en) | 1998-04-11 | 2010-05-11 | Boston Scientific Scimed, Inc. | Drug-releasing stent with ceramic-containing layer |
US6850803B1 (en) * | 2000-06-16 | 2005-02-01 | Medtronic, Inc. | Implantable medical device with a recharging coil magnetic shield |
AU2002345328A1 (en) | 2001-06-27 | 2003-03-03 | Remon Medical Technologies Ltd. | Method and device for electrochemical formation of therapeutic species in vivo |
US6772011B2 (en) * | 2002-08-20 | 2004-08-03 | Thoratec Corporation | Transmission of information from an implanted medical device |
JP4153852B2 (en) * | 2003-09-18 | 2008-09-24 | オリンパス株式会社 | Energy supply coil and wireless in-vivo information acquisition system using the same |
DE10353943B4 (en) | 2003-11-18 | 2013-01-03 | Deutsches Zentrum für Luft- und Raumfahrt e.V. | Arrangement for the wireless transmission of energy to an implanted device |
US7512443B2 (en) * | 2004-04-30 | 2009-03-31 | Medtronic, Inc. | Spacers for use with transcutaneous energy transfer system |
US7374565B2 (en) * | 2004-05-28 | 2008-05-20 | Ethicon Endo-Surgery, Inc. | Bi-directional infuser pump with volume braking for hydraulically controlling an adjustable gastric band |
US7390294B2 (en) * | 2004-05-28 | 2008-06-24 | Ethicon Endo-Surgery, Inc. | Piezo electrically driven bellows infuser for hydraulically controlling an adjustable gastric band |
US7351240B2 (en) * | 2004-05-28 | 2008-04-01 | Ethicon Endo—Srugery, Inc. | Thermodynamically driven reversible infuser pump for use as a remotely controlled gastric band |
US7481763B2 (en) * | 2004-05-28 | 2009-01-27 | Ethicon Endo-Surgery, Inc. | Metal bellows position feedback for hydraulic control of an adjustable gastric band |
US20050288740A1 (en) * | 2004-06-24 | 2005-12-29 | Ethicon Endo-Surgery, Inc. | Low frequency transcutaneous telemetry to implanted medical device |
US7599743B2 (en) * | 2004-06-24 | 2009-10-06 | Ethicon Endo-Surgery, Inc. | Low frequency transcutaneous energy transfer to implanted medical device |
US20050288739A1 (en) * | 2004-06-24 | 2005-12-29 | Ethicon, Inc. | Medical implant having closed loop transcutaneous energy transfer (TET) power transfer regulation circuitry |
US7191007B2 (en) * | 2004-06-24 | 2007-03-13 | Ethicon Endo-Surgery, Inc | Spatially decoupled twin secondary coils for optimizing transcutaneous energy transfer (TET) power transfer characteristics |
US7599744B2 (en) * | 2004-06-24 | 2009-10-06 | Ethicon Endo-Surgery, Inc. | Transcutaneous energy transfer primary coil with a high aspect ferrite core |
US20060089709A1 (en) * | 2004-10-21 | 2006-04-27 | Helmus Michael N | Medical implant with average surface charge density |
US8840660B2 (en) | 2006-01-05 | 2014-09-23 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
US8089029B2 (en) | 2006-02-01 | 2012-01-03 | Boston Scientific Scimed, Inc. | Bioabsorbable metal medical device and method of manufacture |
US20070224235A1 (en) | 2006-03-24 | 2007-09-27 | Barron Tenney | Medical devices having nanoporous coatings for controlled therapeutic agent delivery |
US8187620B2 (en) | 2006-03-27 | 2012-05-29 | Boston Scientific Scimed, Inc. | Medical devices comprising a porous metal oxide or metal material and a polymer coating for delivering therapeutic agents |
US8048150B2 (en) | 2006-04-12 | 2011-11-01 | Boston Scientific Scimed, Inc. | Endoprosthesis having a fiber meshwork disposed thereon |
US7738965B2 (en) | 2006-04-28 | 2010-06-15 | Medtronic, Inc. | Holster for charging pectorally implanted medical devices |
US7962211B2 (en) | 2006-04-28 | 2011-06-14 | Medtronic, Inc. | Antenna for an external power source for an implantable medical device, system and method |
US8815275B2 (en) | 2006-06-28 | 2014-08-26 | Boston Scientific Scimed, Inc. | Coatings for medical devices comprising a therapeutic agent and a metallic material |
JP2009542359A (en) | 2006-06-29 | 2009-12-03 | ボストン サイエンティフィック リミテッド | Medical device with selective covering |
US9002445B2 (en) * | 2006-07-28 | 2015-04-07 | Boston Scientific Neuromodulation Corporation | Charger with orthogonal PCB for implantable medical device |
US8052743B2 (en) | 2006-08-02 | 2011-11-08 | Boston Scientific Scimed, Inc. | Endoprosthesis with three-dimensional disintegration control |
EP2068757B1 (en) | 2006-09-14 | 2011-05-11 | Boston Scientific Limited | Medical devices with drug-eluting coating |
US8057534B2 (en) | 2006-09-15 | 2011-11-15 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
EP2959925B1 (en) | 2006-09-15 | 2018-08-29 | Boston Scientific Limited | Medical devices and methods of making the same |
WO2008034048A2 (en) | 2006-09-15 | 2008-03-20 | Boston Scientific Limited | Bioerodible endoprosthesis with biostable inorganic layers |
JP2010503489A (en) | 2006-09-15 | 2010-02-04 | ボストン サイエンティフィック リミテッド | Biodegradable endoprosthesis and method for producing the same |
US8002821B2 (en) | 2006-09-18 | 2011-08-23 | Boston Scientific Scimed, Inc. | Bioerodible metallic ENDOPROSTHESES |
US20110009925A1 (en) * | 2006-10-17 | 2011-01-13 | Cochlear Limited | Transcutaneous receiving antenna device for implant |
US7981150B2 (en) | 2006-11-09 | 2011-07-19 | Boston Scientific Scimed, Inc. | Endoprosthesis with coatings |
ES2356274T3 (en) | 2006-12-28 | 2011-04-06 | Boston Scientific Limited | BIODEGRADABLE ENDOPROTESIS AND MANUFACTURING PROCEDURES OF THE SAME. |
US8431149B2 (en) | 2007-03-01 | 2013-04-30 | Boston Scientific Scimed, Inc. | Coated medical devices for abluminal drug delivery |
US8070797B2 (en) | 2007-03-01 | 2011-12-06 | Boston Scientific Scimed, Inc. | Medical device with a porous surface for delivery of a therapeutic agent |
US8067054B2 (en) | 2007-04-05 | 2011-11-29 | Boston Scientific Scimed, Inc. | Stents with ceramic drug reservoir layer and methods of making and using the same |
US7976915B2 (en) | 2007-05-23 | 2011-07-12 | Boston Scientific Scimed, Inc. | Endoprosthesis with select ceramic morphology |
US7942926B2 (en) | 2007-07-11 | 2011-05-17 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US8002823B2 (en) | 2007-07-11 | 2011-08-23 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
EP2187988B1 (en) | 2007-07-19 | 2013-08-21 | Boston Scientific Limited | Endoprosthesis having a non-fouling surface |
US8815273B2 (en) | 2007-07-27 | 2014-08-26 | Boston Scientific Scimed, Inc. | Drug eluting medical devices having porous layers |
US7931683B2 (en) | 2007-07-27 | 2011-04-26 | Boston Scientific Scimed, Inc. | Articles having ceramic coated surfaces |
WO2009018340A2 (en) | 2007-07-31 | 2009-02-05 | Boston Scientific Scimed, Inc. | Medical device coating by laser cladding |
JP2010535541A (en) | 2007-08-03 | 2010-11-25 | ボストン サイエンティフィック リミテッド | Coating for medical devices with large surface area |
US8052745B2 (en) | 2007-09-13 | 2011-11-08 | Boston Scientific Scimed, Inc. | Endoprosthesis |
US7938855B2 (en) | 2007-11-02 | 2011-05-10 | Boston Scientific Scimed, Inc. | Deformable underlayer for stent |
US8216632B2 (en) | 2007-11-02 | 2012-07-10 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US8029554B2 (en) | 2007-11-02 | 2011-10-04 | Boston Scientific Scimed, Inc. | Stent with embedded material |
US20090143673A1 (en) * | 2007-11-30 | 2009-06-04 | Transonic Systems Inc. | Transit time ultrasonic flow measurement |
JP2009158598A (en) * | 2007-12-25 | 2009-07-16 | Panasonic Electric Works Co Ltd | Planar coil and non-contact power transfer device using the same |
WO2009131911A2 (en) | 2008-04-22 | 2009-10-29 | Boston Scientific Scimed, Inc. | Medical devices having a coating of inorganic material |
US8204602B2 (en) * | 2008-04-23 | 2012-06-19 | Medtronic, Inc. | Recharge system and method for deep or angled devices |
WO2009132176A2 (en) | 2008-04-24 | 2009-10-29 | Boston Scientific Scimed, Inc. | Medical devices having inorganic particle layers |
US8509912B2 (en) | 2008-04-30 | 2013-08-13 | Medtronic, Inc. | External power source, system and method for predicting heat loss of implantable medical device during inductive recharging by external primary coil |
US7998192B2 (en) | 2008-05-09 | 2011-08-16 | Boston Scientific Scimed, Inc. | Endoprostheses |
US20110137391A1 (en) * | 2008-06-03 | 2011-06-09 | Leigh C Roger | Foldable coil for an implantable medical device |
US8236046B2 (en) | 2008-06-10 | 2012-08-07 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis |
EP2303350A2 (en) | 2008-06-18 | 2011-04-06 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US7985252B2 (en) | 2008-07-30 | 2011-07-26 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis |
US8382824B2 (en) | 2008-10-03 | 2013-02-26 | Boston Scientific Scimed, Inc. | Medical implant having NANO-crystal grains with barrier layers of metal nitrides or fluorides |
US8231980B2 (en) | 2008-12-03 | 2012-07-31 | Boston Scientific Scimed, Inc. | Medical implants including iridium oxide |
US8267992B2 (en) | 2009-03-02 | 2012-09-18 | Boston Scientific Scimed, Inc. | Self-buffering medical implants |
US8071156B2 (en) | 2009-03-04 | 2011-12-06 | Boston Scientific Scimed, Inc. | Endoprostheses |
US8287937B2 (en) | 2009-04-24 | 2012-10-16 | Boston Scientific Scimed, Inc. | Endoprosthese |
US8690749B1 (en) | 2009-11-02 | 2014-04-08 | Anthony Nunez | Wireless compressible heart pump |
WO2011119573A1 (en) | 2010-03-23 | 2011-09-29 | Boston Scientific Scimed, Inc. | Surface treated bioerodible metal endoprostheses |
US8594806B2 (en) | 2010-04-30 | 2013-11-26 | Cyberonics, Inc. | Recharging and communication lead for an implantable device |
WO2012068247A1 (en) | 2010-11-16 | 2012-05-24 | The Board Of Trustees Of The Leland Stanford Junior University | Systems and methods for treatment of dry eye |
US9821159B2 (en) | 2010-11-16 | 2017-11-21 | The Board Of Trustees Of The Leland Stanford Junior University | Stimulation devices and methods |
US9002469B2 (en) | 2010-12-20 | 2015-04-07 | Abiomed, Inc. | Transcutaneous energy transfer system with multiple secondary coils |
EP4112115A1 (en) | 2010-12-20 | 2023-01-04 | Abiomed, Inc. | Method and apparatus for accurately tracking available charge in a transcutaneous energy transfer system |
US8766788B2 (en) | 2010-12-20 | 2014-07-01 | Abiomed, Inc. | Transcutaneous energy transfer system with vibration inducing warning circuitry |
ES2927951T3 (en) | 2011-04-14 | 2022-11-14 | Abiomed Inc | Transcutaneous energy transfer coil with integrated radio frequency antenna |
US9079043B2 (en) | 2011-11-21 | 2015-07-14 | Thoratec Corporation | Transcutaneous power transmission utilizing non-planar resonators |
US9002468B2 (en) | 2011-12-16 | 2015-04-07 | Abiomed, Inc. | Automatic power regulation for transcutaneous energy transfer charging system |
US8818523B2 (en) * | 2012-04-25 | 2014-08-26 | Medtronic, Inc. | Recharge of an implantable device in the presence of other conductive objects |
WO2013184246A1 (en) * | 2012-04-27 | 2013-12-12 | Med-El Elektromedizinische Geraete Gmbh | Use of defined ferromagnetic materials for optimized implant coil coupling |
US10525181B2 (en) | 2012-07-27 | 2020-01-07 | Tc1 Llc | Resonant power transfer system and method of estimating system state |
WO2014018972A1 (en) | 2012-07-27 | 2014-01-30 | Thoratec Corporation | Computer modeling for resonant power transfer systems |
WO2014018971A1 (en) | 2012-07-27 | 2014-01-30 | Thoratec Corporation | Resonant power transfer systems with protective algorithm |
US10383990B2 (en) | 2012-07-27 | 2019-08-20 | Tc1 Llc | Variable capacitor for resonant power transfer systems |
WO2014018964A2 (en) | 2012-07-27 | 2014-01-30 | Thoratec Corporation | Thermal management for implantable wireless power transfer systems |
EP2878062A4 (en) | 2012-07-27 | 2016-04-20 | Thoratec Corp | Resonant power transmission coils and systems |
US9287040B2 (en) | 2012-07-27 | 2016-03-15 | Thoratec Corporation | Self-tuning resonant power transfer systems |
US9805863B2 (en) | 2012-07-27 | 2017-10-31 | Thoratec Corporation | Magnetic power transmission utilizing phased transmitter coil arrays and phased receiver coil arrays |
US9343923B2 (en) | 2012-08-23 | 2016-05-17 | Cyberonics, Inc. | Implantable medical device with backscatter signal based communication |
US9935498B2 (en) | 2012-09-25 | 2018-04-03 | Cyberonics, Inc. | Communication efficiency with an implantable medical device using a circulator and a backscatter signal |
WO2014138709A1 (en) | 2013-03-08 | 2014-09-12 | Oculeve, Inc. | Devices and methods for treating dry eye in animals |
EP2967817B1 (en) | 2013-03-12 | 2021-03-10 | Oculeve, Inc. | Implant delivery devices and systems |
US9680310B2 (en) | 2013-03-15 | 2017-06-13 | Thoratec Corporation | Integrated implantable TETS housing including fins and coil loops |
WO2014145895A1 (en) | 2013-03-15 | 2014-09-18 | Thoratec Corporation | Malleable tets coil with improved anatomical fit |
US9446241B2 (en) | 2013-03-15 | 2016-09-20 | Alfred E. Mann Foundation For Scientific Research | Current sensing multiple output current stimulators |
CN105307718B (en) | 2013-04-19 | 2018-05-11 | 奥库利维公司 | Nose stimulating apparatus and method |
EP3027270B1 (en) | 2013-07-29 | 2023-10-04 | The Alfred E. Mann Foundation for Scientific Research | Microprocessor controlled class e driver |
US9855437B2 (en) | 2013-11-11 | 2018-01-02 | Tc1 Llc | Hinged resonant power transfer coil |
JP6521992B2 (en) | 2013-11-11 | 2019-05-29 | ティーシー1 エルエルシー | Resonance power transmission system having communication |
WO2015070205A1 (en) | 2013-11-11 | 2015-05-14 | Thoratec Corporation | Resonant power transfer systems with communications |
AU2015223184B2 (en) | 2014-02-25 | 2020-07-02 | Oculeve, Inc. | Polymer formulations for nasolacrimal stimulation |
WO2015134871A1 (en) | 2014-03-06 | 2015-09-11 | Thoratec Corporation | Electrical connectors for implantable devices |
ES2792856T3 (en) | 2014-07-25 | 2020-11-12 | Oculeve Inc | Stimulation patterns to treat dry eyes |
CA2957967C (en) | 2014-08-15 | 2018-11-27 | Axonics Modulation Technologies, Inc. | Systems and methods for neurostimulation electrode configurations based on neural localization |
WO2016025913A1 (en) | 2014-08-15 | 2016-02-18 | Axonics Modulation Technologies, Inc. | Electromyographic lead positioning and stimulation titration in a nerve stimulation system for treatment of overactive bladder |
JP6779860B2 (en) | 2014-08-15 | 2020-11-04 | アクソニクス モジュレーション テクノロジーズ インコーポレイテッド | Integrated EMG clinician programming device for use with implantable neurostimulators |
CA2982572C (en) | 2014-08-15 | 2022-10-11 | Axonics Modulation Technologies, Inc. | Implantable lead affixation structure for nerve stimulation to alleviate bladder dysfunction and other indications |
CN107148294B (en) | 2014-08-15 | 2021-08-24 | 艾克索尼克斯股份有限公司 | External pulse generator apparatus for testing neural stimulation and associated methods |
EP3826104B1 (en) | 2014-09-22 | 2023-05-03 | Tc1 Llc | Antenna designs for communication between a wirelessly powered implant to an external device outside the body |
WO2016057525A1 (en) | 2014-10-06 | 2016-04-14 | Thoratec Corporation | Multiaxial connector for implantable devices |
CA2965514A1 (en) | 2014-10-22 | 2016-04-28 | Oculeve, Inc. | Contact lens for increasing tear production |
AU2015335776B2 (en) | 2014-10-22 | 2020-09-03 | Oculeve, Inc. | Stimulation devices and methods for treating dry eye |
US10207108B2 (en) | 2014-10-22 | 2019-02-19 | Oculeve, Inc. | Implantable nasal stimulator systems and methods |
AU2016205049B2 (en) | 2015-01-09 | 2020-05-14 | Axonics Modulation Technologies, Inc. | Improved antenna and methods of use for an implantable nerve stimulator |
US9895546B2 (en) | 2015-01-09 | 2018-02-20 | Axonics Modulation Technologies, Inc. | Patient remote and associated methods of use with a nerve stimulation system |
EP3242721B1 (en) | 2015-01-09 | 2019-09-18 | Axonics Modulation Technologies, Inc. | Attachment devices and associated methods of use with a nerve stimulation charging device |
CN107847731B (en) | 2015-07-10 | 2019-06-28 | 艾克索尼克斯调制技术股份有限公司 | The implantable nerve stimulator and application method of internal electronic equipment with no ASIC |
US10148126B2 (en) | 2015-08-31 | 2018-12-04 | Tc1 Llc | Wireless energy transfer system and wearables |
WO2017062552A1 (en) | 2015-10-07 | 2017-04-13 | Tc1 Llc | Resonant power transfer systems having efficiency optimization based on receiver impedance |
US10426958B2 (en) | 2015-12-04 | 2019-10-01 | Oculeve, Inc. | Intranasal stimulation for enhanced release of ocular mucins and other tear proteins |
AU2017212551B2 (en) | 2016-01-29 | 2021-05-27 | Axonics, Inc. | Methods and systems for frequency adjustment to optimize charging of implantable neurostimulator |
AU2017218157B2 (en) | 2016-02-12 | 2022-09-29 | Axonics, Inc. | External pulse generator device and associated methods for trial nerve stimulation |
US10252048B2 (en) | 2016-02-19 | 2019-04-09 | Oculeve, Inc. | Nasal stimulation for rhinitis, nasal congestion, and ocular allergies |
AU2017260237A1 (en) | 2016-05-02 | 2018-11-22 | Oculeve, Inc. | Intranasal stimulation for treatment of meibomian gland disease and blepharitis |
US10898292B2 (en) | 2016-09-21 | 2021-01-26 | Tc1 Llc | Systems and methods for locating implanted wireless power transmission devices |
KR20190124698A (en) | 2016-12-02 | 2019-11-05 | 오큘레브, 인크. | Apparatus and Method for Dry Eye Prediction and Treatment Recommendations |
US11197990B2 (en) | 2017-01-18 | 2021-12-14 | Tc1 Llc | Systems and methods for transcutaneous power transfer using microneedles |
EP3634528B1 (en) | 2017-06-07 | 2023-06-07 | Shifamed Holdings, LLC | Intravascular fluid movement devices, systems, and methods of use |
CN111556763B (en) | 2017-11-13 | 2023-09-01 | 施菲姆德控股有限责任公司 | Intravascular fluid movement device and system |
US10770923B2 (en) | 2018-01-04 | 2020-09-08 | Tc1 Llc | Systems and methods for elastic wireless power transmission devices |
CN117959583A (en) | 2018-02-01 | 2024-05-03 | 施菲姆德控股有限责任公司 | Intravascular blood pump and methods of use and manufacture |
EP3755418B1 (en) | 2018-02-22 | 2023-06-21 | Axonics, Inc. | Neurostimulation leads for trial nerve stimulation |
US11642537B2 (en) | 2019-03-11 | 2023-05-09 | Axonics, Inc. | Charging device with off-center coil |
US11439829B2 (en) | 2019-05-24 | 2022-09-13 | Axonics, Inc. | Clinician programmer methods and systems for maintaining target operating temperatures |
US11848090B2 (en) | 2019-05-24 | 2023-12-19 | Axonics, Inc. | Trainer for a neurostimulator programmer and associated methods of use with a neurostimulation system |
WO2021011473A1 (en) | 2019-07-12 | 2021-01-21 | Shifamed Holdings, Llc | Intravascular blood pumps and methods of manufacture and use |
US11654275B2 (en) | 2019-07-22 | 2023-05-23 | Shifamed Holdings, Llc | Intravascular blood pumps with struts and methods of use and manufacture |
US11724089B2 (en) | 2019-09-25 | 2023-08-15 | Shifamed Holdings, Llc | Intravascular blood pump systems and methods of use and control thereof |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS52151835A (en) | 1976-04-30 | 1977-12-16 | Univ Johns Hopkins | Enclosed battery |
US4143661A (en) | 1977-12-12 | 1979-03-13 | Andros Incorporated | Power supply for body implant and method for operation |
JPS56106663A (en) | 1980-01-31 | 1981-08-25 | Tokyo Shibaura Electric Co | Transmitting medium for energy to organism buried device |
US4441498A (en) | 1982-05-10 | 1984-04-10 | Cardio-Pace Medical, Inc. | Planar receiver antenna coil for programmable electromedical pulse generator |
US4665896A (en) | 1985-07-22 | 1987-05-19 | Novacor Medical Corporation | Power supply for body implant and method of use |
US5876425A (en) | 1989-09-22 | 1999-03-02 | Advanced Bionics Corporation | Power control loop for implantable tissue stimulator |
CA2007439C (en) * | 1990-01-09 | 1996-08-13 | John Miller | Transcutaneous energy transfer device |
US5350413B1 (en) | 1990-06-21 | 1999-09-07 | Heart Inst Research Corp | Transcutaneous energy transfer device |
US5109843A (en) | 1990-11-30 | 1992-05-05 | University Of Cincinnati | Extra to-intracorporeal power supply |
DE4104359A1 (en) | 1991-02-13 | 1992-08-20 | Implex Gmbh | CHARGING SYSTEM FOR IMPLANTABLE HOERHILFEN AND TINNITUS MASKERS |
US5314453A (en) | 1991-12-06 | 1994-05-24 | Spinal Cord Society | Position sensitive power transfer antenna |
US5193540A (en) | 1991-12-18 | 1993-03-16 | Alfred E. Mann Foundation For Scientific Research | Structure and method of manufacture of an implantable microstimulator |
US5193539A (en) | 1991-12-18 | 1993-03-16 | Alfred E. Mann Foundation For Scientific Research | Implantable microstimulator |
US5676651A (en) | 1992-08-06 | 1997-10-14 | Electric Boat Corporation | Surgically implantable pump arrangement and method for pumping body fluids |
US5591217A (en) | 1995-01-04 | 1997-01-07 | Plexus, Inc. | Implantable stimulator with replenishable, high value capacitive power source and method therefor |
US5702431A (en) | 1995-06-07 | 1997-12-30 | Sulzer Intermedics Inc. | Enhanced transcutaneous recharging system for battery powered implantable medical device |
US5690693A (en) | 1995-06-07 | 1997-11-25 | Sulzer Intermedics Inc. | Transcutaneous energy transmission circuit for implantable medical device |
EP0902999A1 (en) | 1996-06-04 | 1999-03-24 | Murphy, Timothy M. | A device for transferring electromagnetic energy between primary and secondary coils |
US5755748A (en) | 1996-07-24 | 1998-05-26 | Dew Engineering & Development Limited | Transcutaneous energy transfer device |
US5733313A (en) | 1996-08-01 | 1998-03-31 | Exonix Corporation | RF coupled, implantable medical device with rechargeable back-up power source |
US5715837A (en) | 1996-08-29 | 1998-02-10 | Light Sciences Limited Partnership | Transcutaneous electromagnetic energy transfer |
US5713939A (en) | 1996-09-16 | 1998-02-03 | Sulzer Intermedics Inc. | Data communication system for control of transcutaneous energy transmission to an implantable medical device |
US5749909A (en) | 1996-11-07 | 1998-05-12 | Sulzer Intermedics Inc. | Transcutaneous energy coupling using piezoelectric device |
US5741316A (en) | 1996-12-02 | 1998-04-21 | Light Sciences Limited Partnership | Electromagnetic coil configurations for power transmission through tissue |
DE69826675T2 (en) * | 1997-08-01 | 2006-02-16 | Alfred E. Mann Foundation For Scientific Research, Valenica | IMPLANTABLE DEVICE WITH IMPROVED ARRANGEMENT FOR BATTERY CHARGING AND ENERGY SUPPLY |
US5945762A (en) | 1998-02-10 | 1999-08-31 | Light Sciences Limited Partnership | Movable magnet transmitter for inducing electrical current in an implanted coil |
US5948006A (en) | 1998-10-14 | 1999-09-07 | Advanced Bionics Corporation | Transcutaneous transmission patch |
-
2000
- 2000-05-10 US US09/567,942 patent/US6327504B1/en not_active Expired - Lifetime
-
2001
- 2001-05-10 WO PCT/US2001/015152 patent/WO2001085250A1/en active Application Filing
- 2001-05-10 DE DE60143519T patent/DE60143519D1/en not_active Expired - Lifetime
- 2001-05-10 EP EP01935288A patent/EP1280581B1/en not_active Expired - Lifetime
- 2001-05-10 AU AU2001261396A patent/AU2001261396A1/en not_active Abandoned
- 2001-12-04 US US10/004,731 patent/US20020123777A1/en not_active Abandoned
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7794499B2 (en) | 2004-06-08 | 2010-09-14 | Theken Disc, L.L.C. | Prosthetic intervertebral spinal disc with integral microprocessor |
US7191013B1 (en) | 2004-11-08 | 2007-03-13 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Hand held device for wireless powering and interrogation of biomems sensors and actuators |
US7771351B1 (en) * | 2005-05-27 | 2010-08-10 | The Cleveland Clinic Foundation | Method and apparatus for eddy current compensation in a radio frequency probe |
US7931598B2 (en) | 2005-11-23 | 2011-04-26 | Vital Sensors Holding Company, Inc. | Implantable pressure monitor |
US20100174201A1 (en) * | 2005-11-23 | 2010-07-08 | Vital Sensors Holding Company, Inc. | Anchored implantable pressure monitor |
US20100185103A1 (en) * | 2005-11-23 | 2010-07-22 | Vital Sensors Holding Company, Inc. | Implantable pressure monitor |
US7686768B2 (en) | 2005-11-23 | 2010-03-30 | Vital Sensors Holding Company, Inc. | Implantable pressure monitor |
US7682313B2 (en) | 2005-11-23 | 2010-03-23 | Vital Sensors Holding Company, Inc. | Implantable pressure monitor |
US20070118038A1 (en) * | 2005-11-23 | 2007-05-24 | Vital Sensors Inc. | Implantable device for telemetric measurement of blood pressure/temperature within the heart |
US7931597B2 (en) | 2005-11-23 | 2011-04-26 | Vital Sensors Holding Company, Inc. | Anchored implantable pressure monitor |
US20110201948A1 (en) * | 2005-11-23 | 2011-08-18 | Vital Sensors Holding Company, Inc. | Implantable pressure monitor |
US20110201949A1 (en) * | 2005-11-23 | 2011-08-18 | Vital Sensors Holding Company, Inc. | Anchored implantable pressure monitor |
US8376953B2 (en) | 2005-11-23 | 2013-02-19 | Vital Sensors Holding Company, Inc. | Implantable pressure monitor |
US8382677B2 (en) | 2005-11-23 | 2013-02-26 | Vital Sensors Holding Company, Inc. | Anchored implantable pressure monitor |
US20110166619A1 (en) * | 2008-06-18 | 2011-07-07 | Nasophlex B.V | Ear stimulator for producing a stimulation signal to an ear |
US8639343B2 (en) * | 2008-06-18 | 2014-01-28 | Nasophlex B.V. | Ear stimulator for producing a stimulation signal to an ear |
Also Published As
Publication number | Publication date |
---|---|
DE60143519D1 (en) | 2011-01-05 |
AU2001261396A1 (en) | 2001-11-20 |
EP1280581A4 (en) | 2009-09-30 |
EP1280581B1 (en) | 2010-11-24 |
WO2001085250A1 (en) | 2001-11-15 |
US6327504B1 (en) | 2001-12-04 |
EP1280581A1 (en) | 2003-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6327504B1 (en) | Transcutaneous energy transfer with circuitry arranged to avoid overheating | |
US9636508B2 (en) | Inductive charger with magnetic shielding | |
ES2971060T3 (en) | Medical Device Charging and Communication Assemblies for Use with Implantable Signal Generators | |
US20190314564A1 (en) | Transcutaneous energy transfer systems | |
US9333367B2 (en) | Charger with orthogonal PCB for implantable medical device | |
US8862232B2 (en) | Transcutaneous energy transfer module with integrated conversion circuitry | |
US20080027513A1 (en) | Systems And Methods For Using A Butterfly Coil To Communicate With Or Transfer Power To An Implantable Medical Device | |
US20140114373A1 (en) | Intermediate Coupler to Facilitate Charging in an Implantable Medical Device System | |
US9300161B2 (en) | Use of defined ferromagnetic materials for optimized implant coil coupling | |
Tang | A low-operating-voltage wireless intermediate-range scheme for energy and signal transmission by magnetic coupling for implantable devices | |
WO2005000391A1 (en) | Inductive link for a medical implant | |
US20170361110A1 (en) | Multi-Conductor Cable in an External Charger for an Implantable Medical Device | |
Agarkar et al. | Variable Frequency on Wireless Power Transfer for Pacemaker using Embedded Technology | |
Hui et al. | Development of Energy Transmission External Deep Brain Stimulator |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: THORATEC LLC, CALIFORNIA Free format text: CHANGE OF NAME;ASSIGNOR:THORATEC CORPORATION;REEL/FRAME:041474/0173 Effective date: 20151112 |
|
AS | Assignment |
Owner name: TC1 LLC, MINNESOTA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:THORATEC LLC;REEL/FRAME:041528/0333 Effective date: 20161220 |